1. Home
  2. LFTO vs IRON Comparison

LFTO vs IRON Comparison

Compare LFTO & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liftoff Mobile Inc. Common Stock

LFTO

Liftoff Mobile Inc. Common Stock

N/A

Current Price

$15.31

Market Cap

2.6B

Sector

Technology

ML Signal

N/A

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$62.38

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LFTO
IRON
Founded
2011
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2026
2020

Fundamental Metrics

Financial Performance
Metric
LFTO
IRON
Price
$15.31
$62.38
Analyst Decision
Buy
Strong Buy
Analyst Count
17
13
Target Price
$33.40
★ $103.17
AVG Volume (30 Days)
★ 706.8K
559.1K
Earning Date
11-17-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.27
N/A
Revenue
N/A
N/A
Revenue This Year
$28.05
N/A
Revenue Next Year
$15.50
N/A
P/E Ratio
$59.81
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.02
$40.00
52 Week High
$27.94
$99.50

Technical Indicators

Market Signals
Indicator
LFTO
IRON
Relative Strength Index (RSI) 36.10 30.86
Support Level N/A $58.30
Resistance Level $26.23 $82.89
Average True Range (ATR) 0.65 2.51
MACD 0.12 -0.14
Stochastic Oscillator 9.50 34.05

Price Performance

Historical Comparison
LFTO
IRON

About LFTO Liftoff Mobile Inc. Common Stock

Liftoff Mobile Inc is a growth and monetization engine built for the mobile app economy. Its AI-powered platform, Cortex, unifies marketing, creative, and monetization to deliver measurable performance at scale across the app lifecycle. Liftoff enables advertisers to unlock profitable user growth while helping app publishers maximize revenue with ad monetization technology. It delivers tools for user acquisition, engagement, and analytics for mobile apps, along with solutions for agencies and marketers to scale brand and performance campaigns. Additional offerings include access to audiences through SDK-direct publishers and premium ad placements, game intelligence tools through GameRefinery, and resources for building and scaling performance-driven ad creative.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: